AP NEWS

Bristol-Myers Squibb to Take Part in Credit Suisse 2018 Health Care Conference

November 7, 2018

NEW YORK--(BUSINESS WIRE)--Nov 7, 2018--Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Credit Suisse Annual Health Care Conference on Wednesday, November 14, 2018 in Scottsdale, AZ. Chris Boerner, chief commercial officer, will answer questions about the company at 8 a.m. MT (10 a.m. ET).

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at  BMS.com  or follow us on LinkedInTwitter, YouTube and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005011/en/

CONTACT: Bristol-Myers Squibb Company

Media:

Lisa McCormick Lavery,609-252-7602

lisa.mccormicklavery@bms.com

or

Investors:

Tim Power, 609-252-7509

timothy.power@bms.com

or

Bill Szablewski, 609-252-5894

william.szablewski@bms.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS ONCOLOGY PHARMACEUTICAL

SOURCE: Bristol-Myers Squibb Company

Copyright Business Wire 2018.

PUB: 11/07/2018 06:59 AM/DISC: 11/07/2018 06:59 AM

http://www.businesswire.com/news/home/20181107005011/en

AP RADIO
Update hourly